OpenLB
Open Library of Bioscience
Advanced Search
Trends in biotechnology
Oct, 2009;27 (10): 582-90.

Potential of immunomodulatory host defense peptides as novel anti-infectives.

Donna M Easton, Anastasia Nijnik, Matthew L Mayer, Robert E W Hancock
Author Information
  1. Donna M Easton: Centre for Microbial Diseases & Immunity Research, Department of Microbiology & Immunology, Room 232, 2259 Lower Mall Research Station, University of British Columbia, Vancouver, BC Canada V6T 1Z4.
PMID: 19683819 DOI: 10.1016/j.tibtech.2009.07.004

Abstract

A fundamentally new strategy for the treatment of infectious disease is the modulation of host immune responses to enhance clearance of infectious agents and reduce tissue damage due to inflammation. Antimicrobial host defense peptides have been investigated for their potential as a new class of antimicrobial drugs. Recently their immunomodulatory activities have begun to be appreciated. Modulation of innate immunity by synthetic variants of host defense peptides, called innate defense regulators (IDRs), is protective without direct antimicrobial action. We discuss the potential and current limitations in exploiting the immunomodulatory activity of IDRs as a novel anti-infective pathway. IDRs show significant promise and current research is uncovering mechanistic information that will aid in the future development of IDRs for clinical use.

References

  1. Vaccine. 2003 Jun 1;21 Suppl 2:S24-34 [PMID: 12763679]
  2. Lung Cancer. 2008 Jan;59(1):12-23 [PMID: 17764778]
  3. J Immunotoxicol. 2008 Jan;5(1):33-41 [PMID: 18382856]
  4. J Leukoc Biol. 2006 Sep;80(3):509-20 [PMID: 16793910]
  5. J Immunol. 2009 Aug 15;183(4):2688-96 [PMID: 19605696]
  6. J Pharm Pharmacol. 2004 Mar;56(3):285-9 [PMID: 15025852]
  7. Nature. 2007 Oct 4;449(7162):564-9 [PMID: 17873860]
  8. N Engl J Med. 2006 Sep 7;355(10):1018-28 [PMID: 16908486]
  9. Nat Rev Drug Discov. 2006 Jul;5(7):549-63 [PMID: 16773072]
  10. Future Microbiol. 2008 Aug;3(4):437-51 [PMID: 18651815]
  11. Nat Med. 2004 May;10(5):475-80 [PMID: 15122249]
  12. Regul Pept. 2009 Aug 7;156(1-3):104-17 [PMID: 19328825]
  13. Curr Opin Biotechnol. 2008 Dec;19(6):628-36 [PMID: 19000763]
  14. Curr Protein Pept Sci. 2005 Feb;6(1):35-51 [PMID: 15638767]
  15. Antibiot Khimioter. 2002;47(2):20-3 [PMID: 12087719]
  16. Mol Med. 2008 Jul-Aug;14(7-8):528-37 [PMID: 18385817]
  17. Annu Rev Pharmacol Toxicol. 2008;48:171-97 [PMID: 17883327]
  18. Nat Rev Drug Discov. 2009 Apr;8(4):286-95 [PMID: 19337271]
  19. Nat Med. 2007 Aug;13(8):975-80 [PMID: 17676051]
  20. Br J Dermatol. 2007 Dec;157(6):1124-31 [PMID: 17916212]
  21. Nat Rev Cancer. 2008 Apr;8(4):299-308 [PMID: 18354418]
  22. Vaccine. 2009 Mar 23;27(14):2055-64 [PMID: 19428830]
  23. Immunopharmacol Immunotoxicol. 2002 Nov;24(4):627-38 [PMID: 12510794]
  24. Nat Med. 2003 Mar;9(3):269-77 [PMID: 12612576]
  25. J Med Chem. 2009 Apr 9;52(7):2006-15 [PMID: 19296598]
  26. J Leukoc Biol. 2004 Jan;75(1):39-48 [PMID: 12960280]
  27. J Immunol. 2000 May 1;164(9):4804-11 [PMID: 10779788]
  28. Nature. 2007 Jul 26;448(7152):427-34 [PMID: 17653185]
  29. Vaccine. 2002 Oct 4;20(29-30):3498-508 [PMID: 12297395]
  30. J Immunol. 2005 Oct 1;175(7):4662-8 [PMID: 16177113]
  31. Curr Opin Rheumatol. 2008 May;20(3):334-9 [PMID: 18388527]
  32. Infect Immun. 2005 Jan;73(1):583-91 [PMID: 15618198]
  33. Curr Pharm Des. 2005;11(6):801-11 [PMID: 15777234]
  34. Int Immunol. 2006 Dec;18(12):1729-36 [PMID: 17041145]
  35. Nat Med. 2005 Apr;11(4 Suppl):S63-8 [PMID: 15812492]
  36. J Immunol. 2003 Mar 1;170(5):2274-8 [PMID: 12594247]
  37. J Innate Immun. 2009;1(3):254-67 [PMID: 20375583]
  38. J Immunol. 2004 Jan 15;172(2):1146-56 [PMID: 14707090]
  39. Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3806-11 [PMID: 19234121]
  40. Nat Med. 2004 Dec;10(12 Suppl):S70-6 [PMID: 15577934]
  41. Science. 2002 Nov 1;298(5595):1025-9 [PMID: 12411706]
  42. Blood. 2008 Aug 15;112(4):1461-71 [PMID: 18490516]
  43. J Immunol. 2005 Apr 1;174(7):4271-8 [PMID: 15778390]
  44. Mol Syst Biol. 2008;4:218 [PMID: 18766178]
  45. IDrugs. 2003 Dec;6(12):1188-94 [PMID: 14666431]
  46. Surgeon. 2006 Dec;4(6):355-61 [PMID: 17152200]
  47. ACS Chem Biol. 2009 Jan 16;4(1):65-74 [PMID: 19055425]
  48. J Clin Invest. 2003 Jun;111(11):1665-72 [PMID: 12782669]
  49. J Immunol. 2004 Apr 15;172(8):4987-94 [PMID: 15067080]
  50. Peptides. 2003 Nov;24(11):1681-91 [PMID: 15019199]
  51. Lancet. 2006 Apr 15;367(9518):1247-55 [PMID: 16631880]
  52. Antimicrob Agents Chemother. 2005 May;49(5):1727-32 [PMID: 15855488]
  53. Mol Biosyst. 2009 May;5(5):483-96 [PMID: 19381363]
  54. Trends Immunol. 2007 Jun;28(6):260-6 [PMID: 17468048]
  55. Drug Discov Today. 2007 Jan;12(1-2):80-7 [PMID: 17198976]
  56. Nat Biotechnol. 2006 Dec;24(12):1551-7 [PMID: 17160061]
  57. Clin Diagn Lab Immunol. 2002 Sep;9(5):972-82 [PMID: 12204946]
  58. Vaccine. 2009 Jul 23;27(34):4662-71 [PMID: 19539585]
  59. Peptides. 2003 Nov;24(11):1747-52 [PMID: 15019206]
  60. J Leukoc Biol. 2005 Apr;77(4):451-9 [PMID: 15569695]
  61. Nat Med. 2007 May;13(5):552-9 [PMID: 17479101]
  62. J Immunol. 2003 Dec 15;171(12):6690-6 [PMID: 14662872]
  63. Eur J Immunol. 2001 Apr;31(4):1066-75 [PMID: 11298331]
  64. Breast Cancer Res. 2009;11(1):R6 [PMID: 19183447]
  65. Inflamm Bowel Dis. 2005 Aug;11(8):713-9 [PMID: 16043985]
  66. Curr Protein Pept Sci. 2003 Oct;4(5):339-56 [PMID: 14529528]
  67. Curr Opin Gastroenterol. 2007 Jan;23(1):32-8 [PMID: 17133082]
  68. Clin Infect Dis. 2008 Jan 15;46(2):155-64 [PMID: 18171244]
  69. Nat Biotechnol. 2007 Apr;25(4):465-72 [PMID: 17384586]
  70. Vet Immunol Immunopathol. 2009 Mar 15;128(1-3):184-91 [PMID: 19042032]
  71. J Immunol. 2006 Feb 15;176(4):2455-64 [PMID: 16456005]
  72. Nat Med. 2004 Nov;10(11):1177-85 [PMID: 15516917]
  73. Peptides. 2003 Nov;24(11):1647-54 [PMID: 15019196]
  74. Shock. 2009 Mar;31(3):285-91 [PMID: 18654091]
  75. J Invest Dermatol. 2008 Jan;128(1):223-36 [PMID: 17805349]
  76. Hum Gene Ther. 2009 Apr;20(4):303-13 [PMID: 19272013]
  77. Nat Rev Immunol. 2003 Sep;3(9):710-20 [PMID: 12949495]
  78. Vaccine. 2006 Jun 29;24(26):5461-72 [PMID: 16678312]
  79. J Endotoxin Res. 2006;12(5):261-77 [PMID: 17059690]

MeSH Term

Anti-Infective Agents
Antimicrobial Cationic Peptides
Communicable Diseases
Humans
Immunologic Factors

Chemicals

Anti-Infective Agents
Antimicrobial Cationic Peptides
Immunologic Factors
Journal Article Research Support, Non-U.S. Gov't Review
Article has an altmetric score of 6

Word Cloud

Created with Highcharts 10.0.0hostdefenseIDRspeptidesimmunomodulatorynewinfectiouspotentialantimicrobialinnatecurrentnovelfundamentallystrategytreatmentdiseasemodulationimmuneresponsesenhanceclearanceagentsreducetissuedamagedueinflammationAntimicrobialinvestigatedclassdrugsRecentlyactivitiesbegunappreciatedModulationimmunitysyntheticvariantscalledregulatorsprotectivewithoutdirectactiondiscusslimitationsexploitingactivityanti-infectivepathwayshowsignificantpromiseresearchuncoveringmechanisticinformationwillaidfuturedevelopmentclinicalusePotentialanti-infectives

Similar Articles

Cited By